7Baggers
 Hepion Pharmaceuticals, Inc. SEC 10-Q Report  TradingView Wed, 12 Nov 2025 19:53:00 GMT
 ctrvp sec filings  Stock Titan Wed, 12 Nov 2025 19:44:42 GMT
 published on: 2025-11-02 22:32:49  newser.com Mon, 03 Nov 2025 03:32:49 GMT
 published on: 2025-11-02 21:15:57  newser.com Mon, 03 Nov 2025 02:15:57 GMT
 published on: 2025-10-30 04:20:18  newser.com Thu, 30 Oct 2025 09:20:18 GMT
 published on: 2025-10-29 04:56:27  newser.com Wed, 29 Oct 2025 09:56:27 GMT
 published on: 2025-10-29 03:55:26  newser.com Wed, 29 Oct 2025 08:55:26 GMT

Hepion Pharmaceuticals, Inc
(NASDAQ:HEPA) 

HEPA stock logo

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that is in Phase 2a clinical trials to target multiple pathologic pathways inv...

Founded: 2013
Full Time Employees: 12
CEO: Robert Foster  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends